Navigation Links
Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
Date:6/26/2010

, respectively.  Drug-related hypoglycemia was reported in the placebo + metformin + sulfonylurea group (7.6 percent) at about half the frequency reported in the linagliptin + metformin+ sulfonylurea group (14.5 percent).  No significant changes in weight were noted for either treatment group.(3)
  • Patients in the linagliptin and pioglitazone group were more likely to achieve a target HbA1c <7.0 percent versus those on placebo and pioglitazone (42.9 percent versus 30.5 percent, respectively, p=0.0051).4
    • The proportion of patients who experienced at least one AE was similar for both linagliptin and placebo (52.5 percent versus 53.1 percent, respectively).  Hypoglycemia occurred in 3 patients (1.2 percent) in the linagliptin + pioglitazone group and none in the placebo + pioglitazone group. All hypoglycemic events were of mild intensity.(4)

  • About diabetes

    Approximately 27 million Americans and 285 million people worldwide have diabetes.(9) Type 2 diabetes is the most common type, accounting for more than 90 percent of all diabetes cases in the developed world.(10) Each year, more than 231,000 people in North America and more than 3.96 million people worldwide die from diabetes and its complications(9) – a number which is expected to increase by more than 50 percent over the next decade.(10) Diabetes is a chronic disease that occurs when the body either does not properly produce, or use the hormone, insulin.(11)

    About Boehringer Ingelheim and diabetes

    Metabolism is one of Boehringer Ingelheim's core R&D areas and diabetes is one of the indications at the center of interest within the company's global research network. Boehringer Ingelheim is committed to
    '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
    2. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
    3. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
    4. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
    5. Boehringer Ingelheim Animal Health Closes Deal to Acquire a Significant Portion of the Fort Dodge Animal Health Business From Pfizer
    6. Boehringer Ingelheim Unveils Diabetes Pipeline
    7. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
    8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
    9. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
    10. Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration
    11. MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... 1, 2015 The Institute for Healthcare Advancement ... award winners. The IHA Health Literacy Awards aim to ... on the practice of educating or empowering organizations to ... awards in three categories: innovative programs, published materials and ... Hero award. In the area of innovative ...
    (Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
    (Date:5/1/2015)... NEW YORK , May 1, 2015  Shares ... over 70% of their value yesterday following the results ... company,s glaucoma therapy, Rhopressa.  Despite the trial failing to ... indicates that positive results may come from future studies. ... a brief company overview, current pipeline, financial review, analyst ...
    Breaking Medicine Technology:Institute for Healthcare Advancement Announces 2015 Award Winners 2Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
    ... LAGUNA NIGUEL, Calif., Dec. 12, 2011  Inspiration Biopharmaceuticals, Inc. ... Company,s two lead hemophilia development programs - IB1001, a ... clinical trials for the treatment and prevention of ... an intravenous recombinant porcine factor VIII (FVIII) product, ...
    ... MALVERN, Pa., Dec. 11, 2011   TetraLogic Pharmaceuticals , ... drugs to treat cancer, today announced the oral presentation ... TL32711 at the 53rd ASH Annual Meeting and Exposition ... of Texas M. D. Anderson Cancer Center, demonstrated that ...
    Cached Medicine Technology:Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 2Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 3Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 4Inspiration Biopharmaceuticals Presents Key Scientific Data from its Two Lead Hemophilia Development Programs at the 53rd Annual Meeting of the American Society of Hematology (ASH) 5TetraLogic Pharmaceuticals Announces Oral Presentation on Smac Mimetic TL32711 at American Society of Hematology (ASH) Annual Meeting 2
    (Date:5/3/2015)... May 03, 2015 HealthPostures, a ... solutions, announces its appearance at the , May 5 ... that HealthPostures will exhibit at the conference include its ... sit stand solutions is the 6100 TaskMate Executive. Features ... control, an adjustable keyboard tray, extended platform work surface ...
    (Date:5/2/2015)... (PRWEB) May 02, 2015 Vancouver fencing company, ... now provide valuable advice to prospective clients related to their ... looking to install railings around their decks and patios. While ... questions that pop up once the person rolls up their ... of installing a railing in finding a gate that matches ...
    (Date:5/2/2015)... May 02, 2015 It’s a pattern ... natural disaster strikes anywhere on this planet, cyber scammers ... sympathy and compassion for their own personal gain. ... Emergency Readiness Team) issued an alert titled “Nepal ... email scams citing the earthquake in Nepal. The scam ...
    (Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
    (Date:5/2/2015)... 2015 ZoomCare, the Portland-based innovator of ... to offer its new healthcare insurance to individuals and ... Health Insurance System is the nation’s first health insurance ... performance. ZOOM+ Personal Health Insurance was ZoomCare’s first such ... are subject to review and regulation by the Oregon ...
    Breaking Medicine News(10 mins):Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:ZoomCare Applies to be on Oregon Exchange 2
    ... LOS ANGELES, Dec. 11 At its 12th ... Group presented its Help Humanitarian Award to Steve,Mosko, ... his vibrant,humanitarian spirit and commitment to children with ... audience with his,performance of Conviction of the Heart. ...
    ... up-front preventive benefits add value to consumer-directed plan , ... Consumers are looking for ways to make the most of ... solution with Regence HSA Healthplan 2.0, which helps members manage ... Regence HSA Healthplan 2.0 pairs a high-deductible plan with a ...
    ... SAN ANTONIO - As cancer researchers move away from ... approaches, scientists are working to discover effective ways to ... San Antonio Breast Cancer Symposium illustrate the cutting edge ... Reductions in Breast Density Predict Potential Benefit of Tamoxifen ...
    ... Dec. 12 Alfacell Corporation (Nasdaq: ACEL ... financial officer and corporate secretary, will resign as an employee ... on the board of directors of Alfacell and will also ... until at least January 31, 2009. Mr. Kenyon has ...
    ... 12 Ogilvy Public Relations Worldwide (Ogilvy PR), ... has been awarded a five-year comprehensive communications support contract ... and Education. The work will be performed by Ogilvy ... the company,s life sciences consulting subsidiary, Feinstein Kean Healthcare ...
    ... Researchers not sure whether one causes the other, or ... 12 (HealthDay News) -- Adults who have panic disorder ... attacks and heart disease, but not heart-related deaths, a ... records of almost 58,000 adults diagnosed with panic disorder/attacks ...
    Cached Medicine News:Health News:The Help Group's Teddy Bear Ball Salutes Sony Pictures Television President, Steve Mosko and Features Performance by Kenny Loggins 2Health News:Regence Unveils New Approach to Healthcare With Launch of HSA Healthplan 2.0 2Health News:Biomarkers: What can they tell us 2Health News:Alfacell Announces Management Update 2Health News:Alfacell Announces Management Update 3Health News:National Cancer Institute Selects Ogilvy Public Relations Worldwide for Comprehensive Multi-Year Communications Support 2Health News:Panic Disorder Linked to Higher Risk of Heart Disease 2
    ... From Medtronic, Inc., the leader in beating ... Positioner. The new Starfish NS device is ... to broaden patient acceptance of surgical revascularization.,The ... Perform the Multi-Vessel Small Thoracotomy (MVST) ...
    ... system is a key component ... CAB procedures. This expertly crafted ... mounting options. The unique rail ... blade configurations as well as ...
    ... Guidant's fourth generation access device - XPOSE ... the heart. The XPOSE 4 Device is ... off-pump bypass surgery and to easily position ... Designed for both apical and non-apical placement ...
    ... fit in tight spaces easily? Introducing ... - the latest innovation in mechanical ... equipped with low-profile feet, innovative FlexLink ... greater reach, maneuverability, and access to ...
    Medicine Products: